Lewis Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Lewis Asset Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $19.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$19.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 14,710 | $3.6M |
| ABBVAbbVie Inc. | 13,589 | $3.0M |
| LLYELI LILLY & Co | 2,681 | $2.5M |
| VKTXViking Therapeutics, Inc. | 64,090 | $2.1M |
| ABTABBOTT LABORATORIES | 16,888 | $1.7M |
| AMGNAMGEN INC | 3,389 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,343 | $1.2M |
| PMPhilip Morris International Inc | 6,331 | $1.0M |
| CRNXCrinetics Pharmaceuticals, Inc. | 26,155 | $950K |
| MCKMcKesson Corporation | 1,040 | $900K |
| BMYBRISTOL MYERS SQUIBB CO | 11,551 | $701K |
| PFEPFIZER INC | 17,647 | $496K |
| NTLAIntellia Therapeutics, Inc. | 19,770 | $253K |
| CAHCardinal Health Inc. | 988 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.